| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;93:1621-1629.)
© 1996 American Heart Association, Inc.
Articles |
From the Andreas Gruentzig Cardiovascular Center, Emory University, Atlanta, Ga.
Correspondence to Spencer B. King III, MD, Andreas Gruentzig Cardiovascular Center, Emory University Hospital, 1364 Clifton Rd, Suite F606, Atlanta, GA 30322.
Key Words: angioplasty coronary disease revascularization balloon
| Introduction |
|---|
This is the way it is, but it's not the way it was. How did we arrive at this happy ending that is so common today?
Some say that coronary interventions were inevitable and were the natural progression of our expanding knowledge of vascular disease, but it did not happen that way. The development of angioplasty in all its forms (balloons, stents, ablative devices, and other devices) had a single catalyst, but there were many who added reagents to keep the reaction going. Andreas Gruentzig made interventional cardiology possible, and his is a most interesting story.
| Prelude to Angioplasty |
|---|
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |